GlucoTrack Inc. (GCTK) Financial Statements (2025 and earlier)

Company Profile

Business Address 301 RT 17 NORTH
RUTHERFORD, NJ 07070
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments4,4922,3126,0629,82341997
Cash and cash equivalents4,4922,3126,0629,82341997
Receivables    667023
Inventory, net of allowances, customer advances and progress billings    284185171
Inventory    284185171
Other current assets3766743564523
Total current assets:4,8682,3796,10510,229718314
Noncurrent Assets
Operating lease, right-of-use asset  40166187
Property, plant and equipment274069149134150
Restricted cash and investments101951625753
Other undisclosed noncurrent assets     186172
Total noncurrent assets:3759160377564374
TOTAL ASSETS:4,9052,4386,26510,6061,282688
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities8396726318691,5342,064
Accounts payable8396726318691,5342,064
Debt    142 
Other liabilities6733412293925961,157
Other undisclosed current liabilities  2384  
Total current liabilities:1,5121,0138831,3452,2723,222
Noncurrent Liabilities
Long-term debt and lease obligation:   178245 
Liabilities, other than long-term debt196195210197377340
Liability, pension and other postretirement and postemployment benefits     186172
Due to related parties195210197190168
Other liabilities196     
Operating lease, liability  178245
Total noncurrent liabilities:196195227279422340
Total liabilities:1,7081,2081,1101,6242,6943,561
Equity
Equity, attributable to parent, including:3,1971,2305,1558,982(1,412)(2,873)
Common stock201515201163142
Additional paid in capital112,966103,095102,612102,16589,00484,008
Accumulated other comprehensive income (loss)1617(6)15124164
Accumulated deficit(109,853)(101,901)(97,466)(93,399)(90,703)(87,187)
Other undisclosed equity, attributable to parent484    
Total equity:3,1971,2305,1558,982(1,412)(2,873)
TOTAL LIABILITIES AND EQUITY:4,9052,4386,26510,6061,282688

Income Statement (P&L) ($ in thousands)

9/30/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues     20943
Cost of revenue
(Cost of Goods and Services Sold)
   (321)   
Gross profit:   (321) 20943
Operating expenses(7,104)(4,432)(4,040)(3,132)(3,714)(6,582)
Other undisclosed operating income   3216,264 13,077
Operating income (loss):(7,104)(4,432)(4,040)3,132(3,506)6,539
Nonoperating income (expense) (14)(53)338(11)(177)
Loss, foreign currency transaction, before tax      (32)
Other nonoperating income (expense) (14)(53)33811 
Income (loss) from continuing operations before equity method investments, income taxes:(7,104)(4,446)(4,093)3,470(3,516)6,362
Other undisclosed loss from continuing operations before income taxes    (6,166)(0)(13,077)
Loss from continuing operations:(7,104)(4,446)(4,093)(2,696)(3,516)(6,715)
Loss before gain (loss) on sale of properties:(4,093)(2,696)(3,516)(6,715)
Net loss:(7,104)(4,446)(4,093)(2,696)(3,516)(6,715)
Other undisclosed net income (loss) attributable to parent711265,392013,431
Net income (loss) attributable to parent:(7,097)(4,435)(4,067)2,696(3,516)6,715
Other undisclosed net income (loss) available to common stockholders, basic15,049  (5,392) (45,534)
Net income (loss) available to common stockholders, diluted:7,952(4,435)(4,067)(2,696)(3,516)(38,818)

Comprehensive Income ($ in thousands)

9/30/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net loss:(7,104)(4,446)(4,093)(2,696)(3,516)(6,715)
Other comprehensive income (loss)(1)23(21)(109)(40)54
Comprehensive loss:(7,105)(4,423)(4,114)(2,805)(3,556)(6,662)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent78,835265,610013,324
Comprehensive income (loss), net of tax, attributable to parent:(7,098)4,412(4,088)2,805(3,556)6,662

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: